Dr Jesse Morse explains why BPC 157 will never receive FDA approval despite its potential to accelerate healing and recovery from injuries. >> Link When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification The Peptide Craze Ground Truths